RxDoctor Payments Data

Christina Cheng, MD

Orthopaedic Surgery of the Spine · Cleveland, OHNPI 1053600742

Payments from drug & device makers

What this record shows

7 manufacturers reported payments, led by Medical Device Business Services, Inc. at 55.5% of the total. Reporting peaked in 2020 at $1,526 and has fallen 54.9% since, to $689 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in OH, where the typical reported total is $9,469.

$2,811in general payments, 2019–2025

Across 24 payments — averaging $117.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • Globus Medical$786
  • Innovation Technologies Inc$158
  • Boston Scientific$137
  • Arteriocyte Medical Systems, Inc.$101
  • Medtronic$37
  • plus $34 from 1 others

What the payments were for

  • Travel & lodging$1,64959%
  • Food & beverage$1,16241%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,811 in reported general payments places this provider in the 25th percentile of 64 orthopaedic surgery of the spine providers in Ohio.

See all orthopaedic surgery of the spine providers in Ohio

Medicare billing

Part B allowed, 2024
$93,012
Medicare patients
143
Services billed
325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin43$335
Methocarbamol20$241
Oxycodone Hcl16$103
Methylprednisolone12$101
Tizanidine Hcl20$77
Meloxicam13$11

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →